Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manu Pandey

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Future Oncology (London, England)|August 25, 2017
Challenges faced when identifying patients for combination immunotherapyMarc S Ernstoff, Shipra Gandhi, Manu Pandey, et al.
Radiology. Imaging Cancer|December 13, 2024
<sup>18</sup>F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell TransplantationJennifer Holter-Chakrabarty, Lacey McNally, John Levine, et al.
Nature Communications|March 30, 2024
Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignanciesSaeed Daneshmandi, Jee Eun Choi, Qi Yan, et al.
Blood Advances|January 26, 2022
Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapyJurjen Versluis, Manu Pandey, Yael Flamand, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Future Oncology (London, England)|August 25, 2017
Challenges faced when identifying patients for combination immunotherapyMarc S Ernstoff, Shipra Gandhi, Manu Pandey, et al.
Radiology. Imaging Cancer|December 13, 2024
<sup>18</sup>F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell TransplantationJennifer Holter-Chakrabarty, Lacey McNally, John Levine, et al.
Nature Communications|March 30, 2024
Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignanciesSaeed Daneshmandi, Jee Eun Choi, Qi Yan, et al.
Blood Advances|January 26, 2022
Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapyJurjen Versluis, Manu Pandey, Yael Flamand, et al.
Pageof 2